Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t (Q56966479)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Cesar Ramos-Remus

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gabriele Valentini

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

16

object named as

T K Kvien

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Claire Bombardier

7

object named as

C Bombardier

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

K Visser

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

W Katchamart

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

E Loza

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J A Martinez-Lopez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C Salliot

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Trudeau

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D van der Heijde

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J W J Bijlsma

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D T Boumpas

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C J Edwards

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

V Hamuryudan

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

B F Leeb

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

E M Martín-Mola

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Mielants

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

U Müller-Ladner

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G Murphy

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Østergaard

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

I A Pereira

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Zochling

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Dougados

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

25 November 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 July 2009

2 references

14 November 2020

1 May 2021

Annals of the Rheumatic Diseases

4 references

17 June 2019

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

14 November 2020

1 May 2021

68

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1086-1093

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

copyright license

Creative Commons Attribution-NonCommercial

3 references

17 June 2019

14 November 2020

1 May 2021

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Liver biopsy in psoriatic arthritis to detect methotrexate hepatotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Predictors of infection in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Low dose weekly methotrexate in early pregnancy. A case series and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate exposure prior to and during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Clinical liver disease in patients with rheumatoid arthritis taking methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

2 November 2018

Evidence-based clinical guidelines: a new system to better determine true strength of recommendation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

30 November 2018

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

30 November 2018

Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

30 November 2018

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689523

30 November 2018

Psoriatic arthritis: clinical response and side effects to methotrexate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary function in patients receiving long-term low-dose methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and the medical causes of miscarriage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Rheumatoid Arthritis Clinical Trial Archive Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent use of folinic acid and methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate and the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Rheumatoid arthritis, methotrexate and non-Hodgkins lymphoma. A report of 3 patients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19033291

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2008.094474

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033291%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56966479&oldid=1811149335"